| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/20/2005 | CA2189882C Papillomavirus vaccines |
| 09/20/2005 | CA2170606C Type i angiotensin ii receptor specific monoclonal antibodies and hybridomas |
| 09/20/2005 | CA2143857C Improved method for the quantification of nucleic acid |
| 09/15/2005 | WO2005085853A1 Biochip, process for producing the same and method of detecting chemical substance interaction with the chip |
| 09/15/2005 | WO2005085468A1 Design and therapeutic use of adpase enhanced apyrases |
| 09/15/2005 | WO2005085467A1 Method of detecting protein complex and kit for detecting protein complex |
| 09/15/2005 | WO2005085461A1 Method of decomposing nucleic acid and use thereof |
| 09/15/2005 | WO2005085460A1 Process for producing polyhydroxyalkanoate |
| 09/15/2005 | WO2005085458A2 Polyacetal-peptide mediated transfection |
| 09/15/2005 | WO2005085457A2 Method and products for the selective degradation of proteins |
| 09/15/2005 | WO2005085456A1 New expression tools for multiprotein applications |
| 09/15/2005 | WO2005085455A1 Compositions and methods for treating disease |
| 09/15/2005 | WO2005085454A2 Method for improving productivity of plant by chloroplast technology |
| 09/15/2005 | WO2005085453A2 Seeds |
| 09/15/2005 | WO2005085452A1 Plants having improved yield and method for making the same |
| 09/15/2005 | WO2005085451A2 Polynucleotide phosphorylase (pnpase) as target for herbicides |
| 09/15/2005 | WO2005085450A1 Transgenic expression constructs for vegetative plant tissue specific expression of nucleic acids |
| 09/15/2005 | WO2005085449A2 Stomatal guard cell specific promoter |
| 09/15/2005 | WO2005085448A2 Canine ghrh gene, polypeptides and methdos of use |
| 09/15/2005 | WO2005085447A1 β-FRUCTOFURANOSIDASE MUTANT |
| 09/15/2005 | WO2005085446A1 Method of selecting bird resistant to rna virus |
| 09/15/2005 | WO2005085445A1 Recombinant varicella-zoster virus |
| 09/15/2005 | WO2005085444A1 Chithin oligosaccharide elicitor-binding protein |
| 09/15/2005 | WO2005085443A2 Rnai-based therapeutics for allergic rhinitis and asthma |
| 09/15/2005 | WO2005085442A2 COMPOUNDS FOR HYDROLYSING RIBONUCLEIC ACIDS (RNAs) |
| 09/15/2005 | WO2005085441A1 Modified promoter |
| 09/15/2005 | WO2005085440A1 Method for enriching and/or separating prokaryotic dna using a protein that specifically bonds to unmethylated dna containing cpg-motives |
| 09/15/2005 | WO2005085439A1 Probes for detecting protein nuclear migration and method of detecting and quantifying protein nuclear migration using the same |
| 09/15/2005 | WO2005085438A1 Transgenic nonhuman mammal representing the pathologic conditions of human rheumatoid arthritis |
| 09/15/2005 | WO2005085437A1 Mutant bacterium belonging to the genus bacillus |
| 09/15/2005 | WO2005085436A1 Method of detecting carcinogenesis caused by hepatitis b virus |
| 09/15/2005 | WO2005085435A1 Process for producing picolinic acid compounds |
| 09/15/2005 | WO2005085434A1 Method of preparing genome library and genome library prepared thereby |
| 09/15/2005 | WO2005085433A1 Method of regulating o-glycosylation in eucaryotic cell |
| 09/15/2005 | WO2005085432A1 Substance capable of accelerating nucleotide chain exchange reaction |
| 09/15/2005 | WO2005085430A2 Adzymes and uses thereof |
| 09/15/2005 | WO2005085427A1 Rat embryonic stem cell |
| 09/15/2005 | WO2005085425A1 Method of differentiating mesenchymal stem cells into steroid-producing cells |
| 09/15/2005 | WO2005085417A2 Bacterial system for protein transport in eukaryotic cells |
| 09/15/2005 | WO2005085416A1 Method of screening fungus-specific antimicrobial agent and kit therefor |
| 09/15/2005 | WO2005085415A1 Novel transformant and process for producing polyester by using the same |
| 09/15/2005 | WO2005085291A1 A kind of fusion protein, gene encoding it, expression method and use thereof |
| 09/15/2005 | WO2005085269A1 Nucleotide derivatives and dna microarray |
| 09/15/2005 | WO2005084714A2 Raav-neprilysin compositions and methods of use |
| 09/15/2005 | WO2005084712A2 Use of an oligonucleotide or its active derivative for the preparation of a pharmaceutical composition for inhibiting the formation of metastases in cancer treatment |
| 09/15/2005 | WO2005084707A1 Method of utilizing organic cation transporter oct3-related molecule for treating mental diseases such as depression, anxiety neurosis, drug addiction and the like |
| 09/15/2005 | WO2005084706A1 Mutant strains of brucella melitensis and immunogenic compositions |
| 09/15/2005 | WO2005084691A1 Method of proliferating precursor cells |
| 09/15/2005 | WO2005084430A1 Generation of transgenic avians |
| 09/15/2005 | WO2005084428A1 Epilepsy model animal (chrna4:s284l) |
| 09/15/2005 | WO2005084427A1 Preparation of recombinant rotavirus proteins in milk of transgenic non human mammals |
| 09/15/2005 | WO2005084412A2 Controlled modulation of the pharmacokinetics and biodistribution of aptamer therapeutics |
| 09/15/2005 | WO2005084366A2 Transcription factor rna interference reagents and methods of use thereof |
| 09/15/2005 | WO2005084355A2 Insecticidal toxin complex fusion proteins |
| 09/15/2005 | WO2005084210A2 Multiplex detection probes |
| 09/15/2005 | WO2005084190A2 Methods and compostions for targeted cleavage and recombination |
| 09/15/2005 | WO2005084180A2 Polyamides and polyamide complexes for delivery of oligonucleotide decoys |
| 09/15/2005 | WO2005084115A2 Ttg3 deficient plants, nucleic acids, polypetides and methods of use thereof |
| 09/15/2005 | WO2005068628A3 Methods for nucleic acid isolation and kits using solid phase material |
| 09/15/2005 | WO2005064019A3 Universal amplification of fragmented rna |
| 09/15/2005 | WO2005063990A3 Wuschel (wus) gene homologs |
| 09/15/2005 | WO2005056569A3 Beta integrin gene and protein |
| 09/15/2005 | WO2005052148A3 Expression of granular starch hydrolyzing enzymes in trichoderma and process for producing glucose from granular starch substrates |
| 09/15/2005 | WO2005051421A3 Use of shigella invaplex to transport functional proteins and transcriptionally active nucleic acids across mammalian cell membranes in vitro and in vivo |
| 09/15/2005 | WO2005047458A3 Modified recombinant vaccina viruses and other microorganisms, uses thereof |
| 09/15/2005 | WO2005040428A3 Detection of mutations in a gene associated with resistance to viral infection, oas1 |
| 09/15/2005 | WO2005040377A3 High efficiency gene transfer and expression in mammalian cells by a multiple transfection procedure of matrix attachment region sequences |
| 09/15/2005 | WO2005038001A3 Improved transgenesis by sperm-mediated gene transfer |
| 09/15/2005 | WO2005034841A3 Anthrax vaccine |
| 09/15/2005 | WO2005023837A3 Ebola peptides and immunogenic compositions containing same |
| 09/15/2005 | WO2005014777A3 Methods and compositions for increasing the efficacy of biologically-active ingredients |
| 09/15/2005 | WO2005012496A3 Novel nucleic acids from sesame plants |
| 09/15/2005 | WO2005007871A3 Genetic marker of response to atypical antipsychotics and antidepressants and methods for use thereof |
| 09/15/2005 | WO2005005643A3 Chloroplast transformation of duckweed |
| 09/15/2005 | WO2005003720A3 Method of detecting the cystic fibrosis transmembrane conductance regulator (cftr) at cell exterior |
| 09/15/2005 | WO2005003347A3 Dna-based aptamers for human cathepsin g |
| 09/15/2005 | WO2005002511A3 Recombinant antibodies and compositions and methods for making and using the same |
| 09/15/2005 | WO2004094606A3 COMPOSITIONS AND METHODS FOR siRNA INHIBITION OF ANGIOPOIETIN 1 AND 2 AND THEIR RECEPTOR TIE2 |
| 09/15/2005 | WO2004094472A3 Collagen fibrils carrying bioactive heterologous domains and their use in e.g. wound healing |
| 09/15/2005 | WO2004093810A3 Methods and compositions for treating disorders |
| 09/15/2005 | WO2004089284A3 Targets for tumor growth inhibition |
| 09/15/2005 | WO2004079325B1 Ph dependent signaling dna enzymes |
| 09/15/2005 | WO2004047764A3 Modulation of hiv replication by rna interference |
| 09/15/2005 | WO2004037993A3 Methods of producing a library and methods of selecting polynucleotides of interest |
| 09/15/2005 | WO2004013288A3 Methods and kits for synthesis of sirna expression cassettes |
| 09/15/2005 | WO2003085087A8 Modified cea nucleic acid and expression vectors |
| 09/15/2005 | WO2003000844A3 Protein modification and maintenance molecules |
| 09/15/2005 | US20050204437 Barley for production of flavor-stable beverage |
| 09/15/2005 | US20050204436 Using vector transformation to generate glyphosate resistant crop plants |
| 09/15/2005 | US20050204435 Plant recombination proteins |
| 09/15/2005 | US20050204433 Method for recombinating plastid using procaryotic recombinase gene |
| 09/15/2005 | US20050204432 Br2 and Dw3 promoters and methods of use |
| 09/15/2005 | US20050204431 Use of specific myb genes for the production of transgenic plants tolerant to biotic and abiotic stresses |
| 09/15/2005 | US20050204430 Genetic engineering salt tolerance in crop plants |
| 09/15/2005 | US20050204429 polynucleotide constructs, expression cassettes, vectors, or inserts into the chromosome or as an exogenous element, to modulate in vivo and in vitro transcription of polynucleotides; host cells, plants and seeds |
| 09/15/2005 | US20050204428 Using vector transformation and mutagenesis as tools to identify modulators of nuclear receptor activation |
| 09/15/2005 | US20050204427 Expression vector comprising transcription regulatory protein for use in enhancing heterologous gene expression in plants |
| 09/15/2005 | US20050204425 Isolation of su1, a starch debranching enzyme, the product of the maize gene sugary1 |
| 09/15/2005 | US20050204424 for transgenic plants |
| 09/15/2005 | US20050204423 Using vector transformation to generate plants with altered fatty acid content in glycerolipids and enhanced stress tolerance and growth in reduced phosphorous soils |